HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome

C Belizna, F Pregnolato, S Abad, J Alijotas-Reig, H Amital, Z Amoura, L Andreoli, E Andres, A Aouba, S Apras Bilgen, L Arnaud, B Bienvenu, V Bitsadze, P Blanco, M Blank, MO Borghi, A Caligaro, E Candrea, V Canti, L ChicheJM Chretien, JW Cohen Tervaert, L Damian, T Delross, E Dernis, K Devreese, A Djokovic, E Esteve-Valverde, M Favaro, C Fassot, R Ferrer-Oliveras, A Godon, M Hamidou, M Hasan, D Henrion, B Imbert, PY Jeandel, P Jeannin, P Jego, N Jourde-Chiche, J Khizroeva, O Lambotte, C Landron, JO Latino, E Lazaro, K de Leeuw, T Le Gallou, L Kiliç, M Limper, L Loufrani, R Lubin, N Magy-Bertrand, G Mahe, A Makatsariya, T Martin, C Muchardt, G Nagy, L Omarjee, P Van Paasen, G Pernod, F Perrinet, G Pïres Rosa, MA Pistorius, A Ruffatti, F Said, P Saulnier, D Sene, L Sentilhes, O Shovman, J Sibilia, C Sinescu, N Stanisavljevic, L Stojanovich, LS Tam, A Tincani, F Tollis, S Udry, MN Ungeheuer, M Versini, R Cervera, PL Meroni

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome'. Together they form a unique fingerprint.

Medicine & Life Sciences